Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) EPS (Diluted) (2022 - 2026)

Updated

Provectus Biopharmaceuticals' EPS (Diluted) was $0.00 in Q2 2026, compared with $0.00 a year earlier.

Analysis

Provectus Biopharmaceuticals (PVCT) EPS (Diluted) (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Provectus Biopharmaceuticals' EPS (Diluted) was -$0.01 through Jun 30, 2026; for FY2025, it came in at -$0.01.

  • In earlier years, EPS (Diluted) was -$0.01 in FY2024, -$0.01 in FY2023 and -$0.01 in FY2022.
  • The Q2 2026 figure marks the highest quarterly EPS (Diluted) since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.94
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.09
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.04
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -0.54
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.67
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.60
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -8.44
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -0.04
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 -0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
API Access

Provectus Biopharmaceuticals EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=PVCT&period=max&api_key=YOUR_API_KEY